You must understand that the amount they are making now would be done in small batches primarily produced for their trials. They probably can only afford to give to the public what they have in excess. If/when the product is approved they will likely have to build a dedicated production facility to produce this drug in large batches. Supply is only unreliable now because large scale production is not PAR's focus at this point. From my experience working in a production engineering team I believe this is the reason for the unreliable supply. Hopefully your mum gets it soon.
PPS completed 12 injection course, page-92
-
- There are more pages in this discussion • 126 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.015(6.52%) |
Mkt cap ! $85.7M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 24.5¢ | 23.0¢ | $116.0K | 491.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 33682 | 3 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |